Aster DM Quality Care Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which have been reviewed by the Audit Committee and M/s. Deloitte Haskins & Sells. The unaudited financial results (standalone and consolidated) are available on the company’s website and will be published in newspapers as per listing regulations.
Aster DM Quality Care Announces Financial Results
Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) has officially released its unaudited financial results for the quarter and the six months ended September 30, 2026. The company’s Board of Directors convened on November 6, 2026, to approve these statements. The financial results, presented on both a standalone and consolidated basis, have undergone review by the Audit Committee and have been further reviewed by M/s. Deloitte Haskins & Sells, the statutory auditors. These results will be published in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and are also accessible on the company’s official website, www.asterqualitycare.com.
Key Financial Highlights
For the standalone entity, the revenue from operations for the quarter ended September 30, 2026, stood at INR 1,204.21 crores, with total income reaching INR 1,250.33 crores. Total expenses for the quarter were INR 1,124.18 crores, leading to a profit before tax of INR 111.92 crores. For the six months ended September 30, 2026, standalone revenue from operations was INR 1,929.94 crores, and total income was INR 2,015.09 crores, with profit before tax at INR 122.81 crores.
On a consolidated basis, the revenue from operations for the quarter ended September 30, 2026, was INR 2,829.20 crores, and total income reached INR 2,880.73 crores. Total expenses amounted to INR 2,434.43 crores, resulting in a profit before tax of INR 419.35 crores. For the six months ended September 30, 2026, consolidated revenue from operations was INR 4,139.88 crores, and total income was INR 4,228.44 crores, with profit before tax at INR 497.43 crores.
Significant Corporate Events
The financial results reflect the impact of the Scheme of Amalgamation, effective from July 1, 2026, where Quality Care India Limited merged with Aster DM Healthcare Limited, subsequently renamed Aster DM Quality Care Limited. This amalgamation has been accounted for using the ‘pooling of interests’ method. Additionally, the company acquired an additional 9.00% stake in its subsidiary, United Ciigma Institute of Medical Sciences Private Limited, on September 10, 2026.
Source: BSE
